QUOTE AND NEWS
MarketWatch  Jul 7  Comment 
Compugen Ltd. shares rose almost 4% in premarket trade Monday, after the company said it has achieved an initial milestone in a cancer immunotherapy partnership with Bayer Healthcare, a unit of Bayer AG . The company said the milestone relates to...
Benzinga  Jun 18  Comment 
Analysts at JMP Securities initiated coverage on shares of Compugen (NASDAQ: CGEN) with a “market outperform” rating. The target price for Compugen is set to $14. Compugen's shares closed at $9.06 yesterday. Wedbush initiated coverage on...
Motley Fool  Jun 16  Comment 
Compugen shares ascend to the heavens after disclosing initial data on one of its experimental immune checkpoint candidates. Find out whether or not this pop is deserved.
Benzinga  Jun 16  Comment 
Compugen Ltd. (NASDAQ: CGEN) disclosed today positive experimental results for CGEN-15052, a novel immune checkpoint candidate for cancer immunotherapy, which in several experimental settings demonstrated robust inhibition of T cell...
SeekingAlpha  May 19  Comment 
Compugen Ltd. (CGEN) Q1 2014 Results Earnings Conference Call May 19, 2014 10:00 AM ET Executives Martin Gerstl - Chairman of the Board Dr. Anat Cohen-Dayag - President and CEO Avihai Shen - Interim Chief Financial Officer ...
Wall Street Journal  Apr 7  Comment 
Compugen said it isn't being investigated for insider trading by the Israeli Securities Authority, although CFO's husband is under probe.
TheStreet.com  Mar 19  Comment 
NEW YORK (TheStreet) -- Compugen was given a "buy" rating with a price target of $17 by analysts at Jefferies Group. The Israel-based drug discovery company has a 52-week low of $4.56 and a 52 week high of $14.32. Shares opened at $11.45...
Benzinga  Mar 19  Comment 
Horizon Pharma (NASDAQ: HZNP) surged 20.91% to $17.75 in the pre-market session after the company announced its plans to acquire privately held Vidara Therapeutics International for around $660 million. Exact Sciences (NASDAQ: EXAS) surged...
DailyFinance  Mar 11  Comment 
TORONTO, ONTARIO -- (Marketwired) -- 03/11/14 -- Compugen Inc. is pleased to announce that as part of Microsoft Canada's comprehensive assessment of its partners' capabilities, Compugen will continue to retain the Licensing Solutions Partner (LSP)...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki